SFM
ALXN
Sphera Funds Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-60,000
| Closed | -$9.37M | – | 203 |
|
|
2020
Q4 | $9.37M | Buy |
+60,000
| New | +$9.37M | 0.83% | 27 |
|
|
2020
Q2 | – | Sell |
-249,396
| Closed | -$22.4M | – | 114 |
|
|
2020
Q1 | $22.4M | Buy |
249,396
+133,683
| +116% | +$12M | 2.8% | 8 |
|
|
2019
Q4 | $12.5M | Sell |
115,713
-50,000
| -30% | -$5.41M | 1.03% | 12 |
|
|
2019
Q3 | $16.2M | Sell |
165,713
-171,087
| -51% | -$16.8M | 2.51% | 9 |
|
|
2019
Q2 | $44.1M | Buy |
336,800
+89,500
| +36% | +$11.7M | 6.03% | 2 |
|
|
2019
Q1 | $33.4M | Buy |
247,300
+79,200
| +47% | +$10.7M | 3.05% | 4 |
|
|
2018
Q4 | $16.4M | Buy |
168,100
+26,400
| +19% | +$2.57M | 1.84% | 12 |
|
|
2018
Q3 | $19.7M | Sell |
141,700
-18,844
| -12% | -$2.62M | 2.26% | 8 |
|
|
2018
Q2 | $19.9M | Buy |
160,544
+78,544
| +96% | +$9.75M | 2.75% | 6 |
|
|
2018
Q1 | $9.14M | Sell |
82,000
-38,000
| -32% | -$4.24M | 1.39% | 16 |
|
|
2017
Q4 | $14.4M | Buy |
+120,000
| New | +$14.4M | 1.68% | 8 |
|
|
2017
Q3 | – | Sell |
-100,000
| Closed | -$12.2M | – | 148 |
|
|
2017
Q2 | $12.2M | Buy |
+100,000
| New | +$12.2M | 2.07% | 10 |
|
|
2017
Q1 | – | Sell |
-113,000
| Closed | -$13.8M | – | 125 |
|
|
2016
Q4 | $13.8M | Buy |
113,000
+43,000
| +61% | +$5.26M | 3.5% | 4 |
|
|
2016
Q3 | $8.58M | Buy |
70,000
+27,677
| +65% | +$3.39M | 1.4% | 14 |
|
|
2016
Q2 | $4.94M | Buy |
42,323
+2,323
| +6% | +$271K | 1.28% | 18 |
|
|
2016
Q1 | $5.57M | Sell |
40,000
-19,164
| -32% | -$2.67M | 1.21% | 11 |
|
|
2015
Q4 | $11.3M | Buy |
59,164
+24,164
| +69% | +$4.61M | 1.65% | 9 |
|
|
2015
Q3 | $5.47M | Buy |
+35,000
| New | +$5.47M | 0.7% | 23 |
|
|
2015
Q2 | – | Sell |
-25,000
| Closed | -$4.33M | – | 162 |
|
|
2015
Q1 | $4.33M | Buy |
+25,000
| New | +$4.33M | 0.45% | 49 |
|